These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


289 related items for PubMed ID: 16186434

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of estradiol 1 mg and drospirenone 2 mg in postmenopausal Korean women: a double-blind, randomized, placebo-controlled, multicenter study.
    Lee BS, Kang BM, Yoon BK, Choi H, Park HM, Kim JG.
    Maturitas; 2007 Aug 20; 57(4):361-9. PubMed ID: 17467203
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Estradiol 1 mg and drospirenone 2 mg as hormone replacement therapy in postmenopausal Chinese women.
    Lin SQ, Sun LZ, Lin JF, Yang X, Zhang LJ, Qiao J, Wang ZH, Xu YX, Xiong ZA, Zhou YZ, Wang ML, Zhu J, Chen SR, Su H, Yang CS, Wang SH, Zhang YZ, Dong XJ.
    Climacteric; 2011 Aug 20; 14(4):472-81. PubMed ID: 21469973
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study].
    Zhou YZ, Sun LZ, Lin JF, Yang X, Zhang LJ, Qiao J, Wang ZH, Xu YX, Xiong ZA, Lin SQ.
    Zhonghua Fu Chan Ke Za Zhi; 2011 May 20; 46(5):345-9. PubMed ID: 21733370
    [Abstract] [Full Text] [Related]

  • 13. Effects of the hormone therapy, drospirenone and 17-beta estradiol, on early morning blood pressure in postmenopausal women with hypertension.
    White WB, Hanes V, Mallareddy M, Chauhan V.
    J Am Soc Hypertens; 2008 May 20; 2(1):20-7. PubMed ID: 20409881
    [Abstract] [Full Text] [Related]

  • 14. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep 20; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 15. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy.
    Oelkers WH.
    Climacteric; 2005 Oct 20; 8 Suppl 3():19-27. PubMed ID: 16203652
    [Abstract] [Full Text] [Related]

  • 16. Effect of estradiol-drospirenone hormone treatment on myocardial perfusion reserve in postmenopausal women with angina pectoris.
    Knuuti J, Kalliokoski R, Janatuinen T, Hannukainen J, Kalliokoski KK, Koskenvuo J, Lundt S.
    Am J Cardiol; 2007 Jun 15; 99(12):1648-52. PubMed ID: 17560868
    [Abstract] [Full Text] [Related]

  • 17. Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism.
    Palacios S, Foidart JM, Genazzani AR.
    Maturitas; 2006 Nov 20; 55(4):297-307. PubMed ID: 16949774
    [Abstract] [Full Text] [Related]

  • 18. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb 20; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

  • 19. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL, Glazer R, Weinberger M, Alvarado R, Huang J, Graff A.
    Clin Ther; 2007 Jan 20; 29(1):61-73. PubMed ID: 17379047
    [Abstract] [Full Text] [Related]

  • 20. Drospirenone and estradiol: a new option for the postmenopausal woman.
    Archer DF.
    Climacteric; 2007 Feb 20; 10 Suppl 1():3-10. PubMed ID: 17364592
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.